(Q36751153)

16 August 2017

Detrimental effects of verapamil in patients with primary pulmonary hypertension (English)

1 reference

16 August 2017

1 reference

Packer M

1

1 reference

16 August 2017

Medina N

series ordinal

2

1 reference

16 August 2017

Yushak M

series ordinal

3

1 reference

16 August 2017

Wiener I

series ordinal

4

1 reference

16 August 2017

1 July 1984

1 reference

16 August 2017

British Heart Journal

1 reference

16 August 2017

52

1 reference

16 August 2017

1

1 reference

16 August 2017

106-111

1 reference

Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Primary pulmonary hypertension: effects of nifedipine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Diazoxide in treatment of primary pulmonary hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Verapamil and Pulmonary Hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Effects of Verapamil and Aspirin on Experimental Chronic Hypoxic Pulmonary Hypertension and Right Ventricular Hypertrophy in Rats

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Oral hydralazine therapy for primary pulmonary hypertension.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Nifedipine therapy in angina pectoris: evaluation of safety and side effects

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Effect of beta-receptor blocking agents and related substances on the excitation, contraction and energy metabolism of myocardium fibers

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481593

The hemodynamic effects of isoproterenol on pulmonary hypertension in man

5 September 2018

1 reference

12 December 2020

Primary pulmonary hypertension improved by long-term oral administration of nifedipine

1 reference

12 December 2020

Microarteriographic studies of primary pulmonary hypertension. A quantitative approach in two patients

1 reference

12 December 2020

Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs

1 reference

12 December 2020

Primary pulmonary hypertension favorable effect of isoproterenol

1 reference

12 December 2020

Pulmonary vascular effects of verapamil

1 reference

12 December 2020

Diazoxide in primary pulmonary hypertension

1 reference

12 December 2020

Nifedipine therapy for coronary-artery spasm. Experience in 127 patients

1 reference

12 December 2020

Therapeutic implications of slow-channel blockade in cardiocirculatory disorders

1 reference

12 December 2020

A controlled trial of verapamil for Prinzmetal's variant angina

1 reference

12 December 2020

Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease

1 reference

12 December 2020

Inhibition of Hypoxic Pulmonary Vasoconstriction by Nifedipine

1 reference

12 December 2020

Regression of atherosclerosis in humans: fact or myth?

1 reference

12 December 2020

Deleterious effects of hydralazine in patients with pulmonary hypertension

1 reference

12 December 2020

Sustained beneficial effect of nifedipine in primary pulmonary hypertension

1 reference

12 December 2020

Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's Phenomenon

1 reference

12 December 2020

Nifedipine in the treatment of primary pulmonary hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.52.1.106

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

6743418

1 reference